Skip to main content

1 Result(s)

within Eugeen Vanmechelen Remove this filter Life Sciences Remove this filter

and

  1. Article

    Open Access

    Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

    Alzheimer’s disease (AD) is heterogenous at the molecular level. Understanding this heterogeneity is critical for AD drug development. Here we define AD molecular subtypes using mass spectrometry proteomics in...

    Betty M. Tijms, Ellen M. Vromen, Olav Mjaavatten, Henne Holstege… in Nature Aging (2024)

    Download PDF (6209 KB) View Article